Forced Degradation Profiling and Putative Structural Characterization of Atogepant Degradation Products by LC‐QTOF‐MS/MS Supported by In‐Silico Degradation‐Pathway and Toxicity Assessments
Atogepant is an approved medicine prescribed to be administered by oral route to help prevent migraine headaches in adults. The present study aimed to develop a stability‐indicating RP‐HPLC method for quantifying atogepant and its degradation products (DPs) in atogepant active ingredient. The structure assessment of...